logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Siyue Jia

Jiangsu Provincial Center for Disease Control and Prevention
H指数:6
被引数:296

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immunogenicity and safety of a booster dose of the COVID-19 DNA vaccine in healthy adults aged 18 years and above: a single-center, randomized, observer-blind, placebo-controlled phase 2 trial

COVID-19 DNA疫苗加强针在18岁及以上健康成人中的免疫原性和安全性：一项单中心、随机、观察者盲法、安慰剂对照的II期试验

BMC INFECTIOUS DISEASES
IF3
2025-05-250
OA
Yao, Aihua; Jia, Siyue; Cheng, Xin; Pan, Hongxing; Wang, Zhijian; Yang, Haitao; Xia, Yu; Xu, Jianfang; Huai, Xuefen; Leng, Danjing; Xu, Ming; Wang, Jiarong; Zhao, Gan; Wang, Bin; Li, Jingxin
Effectiveness of a booster dose of aerosolized or intramuscular adenovirus type 5 vectored COVID-19 vaccine in adults: a multicenter, partially randomized, platform trial in China

雾化或肌肉注射腺病毒5型载体COVID-19疫苗加强针的有效性：一项在中国进行的多中心、部分随机、平台试验

NATURE COMMUNICATIONS
IF15.7
2025-03-260
OA
Jia, Siyue; Liu, Yuanbao; He, Qian; Pan, Hongxing; Liang, Zhenglun; Zhou, Juan; Pan, Yingzi; Liu, Sheng; Wu, Jingjing; Yang, Kun; Zhang, Xuanxuan; Zhao, Yang; Li, Simin; Zhang, Lei; Chen, Li; Yao, Aihua; Lu, Mengyi; Zhu, Fengcai; Li, Jingxin
Immunogenicity and safety of a COVID-19 DNA vaccine in healthy adults and elderly: A randomized, observer-blind, placebo-controlled phase 2 trial

COVID-19 DNA疫苗在健康成人和老年人中的免疫原性和安全性: 一项随机，观察者盲，安慰剂对照的2期试验

HUMAN VACCINES & IMMUNOTHERAPEUTICS
IF3.5
2025-01-260
OAAI
Jia, Siyue; Shao, Chengwei; Cheng, Xin; Pan, Hongxing; Wang, Zhijian; Xia, Yu; Xu, Jianfang; Huai, Xuefen; Leng, Danjing; Wang, Jiarong; Zhao, Gan; Wang, Bin; Li, Jingxin; Zhu, Fengcai
Immunogenicity and safety of two-dose or three-dose regimens of inactivated COVID-19 vaccines in patients with pulmonary tuberculosis: a randomised clinical trial

两剂或三剂灭活新型冠状病毒肺炎疫苗在肺结核患者中的免疫原性和安全性: 一项随机临床试验

EXPERT REVIEW OF VACCINES
IF4.8
2024-11-110
OA
Jin, Pengfei; Liu, Qiao; Chen, Wenli; Guo, Xilin; Jiang, Hongmei; Zhang, Ruimei; Ding, Mingdong; Zhang, Kui; Cao, Zhaolan; He, Jiexiao; Jia, Siyue; Wei, Mingwei; Hu, Yuansheng; Cui, Lunbiao; Wang, Jianfeng; Li, Zhuopei; Zhang, Xiaoyin; Xia, Xin; Wu, Yanfei; Zhou, Li; Zhu, Yawen; Gao, Chunjing; Zhang, Tiantian; Zhu, Fengcai; Zeng, Gang; Zhu, Limei; Li, Jingxin
Relative effectiveness of a heterologous booster dose with adenovirus type 5 vectored COVID-19 vaccine versus three doses of inactivated COVID-19 vaccine in adults during a nationwide outbreak of omicron predominance, in China: a retrospective, individually matched cohort-control study
EMERGING MICROBES & INFECTIONS
IF7.5
2024-04-281
OAAI
Jia, Siyue; Yin, Zundong; Pan, Hongxing; Wang, Fuzhen; Liu, Xiaoqiang; Wang, Qing; Zhang, Li; Tang, Jihai; Yang, Hao; Du, Jiangbo; Wang, Zhiguo; Jin, Pengfei; Peng, Zhihang; Tang, Rong; Kang, Guodong; Wang, Xuewen; Li, Simin; Wang, Weixiao; Li, Jingxin; Shen, Hongbing; Zhu, Fengcai
Immune Persistence and Safety After SARS-CoV-2 BNT162b1 mRNA Vaccination in Chinese Adults: A Randomized, Placebo-Controlled, Double-Blind Phase 1 Trial

中国成年人SARS-CoV-2接种BNT162b1 mRNA疫苗后的免疫持久性和安全性: 一项随机、安慰剂对照、双盲1期试验

ADVANCES IN THERAPY
IF4
2022-06-306
OAAI
Li, Jingxin; Hui, Ai-Min; Zhang, Xiang; Ge, Lei; Qiu, Yuanzheng; Tang, Rong; Ye, Huayue; Wang, Xiyuan; Lin, Mei; Zhu, Zhongkui; Zheng, Jianfei; Qiu, Jingjun; Lagkadinou, Eleni; Shpyro, Svetlana; Ozhelvaci, Orkun; Tureci, Ozlem; Khondker, Zakaria; Yin, Wanrong; Shishkova, Yoana; Jia, Siyue; Pan, Hongxing; Peng, Fuzhong; Ma, Zhilong; Wu, Zhenggang; Guo, Xiling; Shi, Yunfeng; Muik, Alexander; Sahin, Ugur; Zhu, Li; Zhu, Fengcai
Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study
NATURE MEDICINE
IF50
2021-04-22103
PREAI
Li, Jingxin; Hui, Aimin; Zhang, Xiang; Yang, Yumei; Tang, Rong; Ye, Huayue; Ji, Ruiru; Lin, Mei; Zhu, Zhongkui; Tureci, Ozlem; Lagkadinou, Eleni; Jia, Siyue; Pan, Hongxing; Peng, Fuzhong; Ma, Zhilong; Wu, Zhenggang; Guo, Xiling; Shi, Yunfeng; Muik, Alexander; Sahin, Ugur; Zhu, Li; Zhu, Fengcai

研究方向

暂未获取到该数据
F
Fengcai Zhu
H 指数:58论文数:390被引数:1.5万
李
李靖欣
H 指数:38论文数:203被引数:7,047
H
Hongxing Pan
H 指数:24论文数:96被引数:4,147
P
Pengfei Jin
H 指数:12论文数:70被引数:779
H
Huayue Ye
H 指数:11论文数:28被引数:552
Y
Yunfeng Shi
H 指数:41论文数:235被引数:8,578
U
Uğur Şahin
H 指数:103论文数:733被引数:6.9万
张希琳 封面图
张希琳
H 指数:80论文数:1,592被引数:2.8万
E
Eleni Lagkadinou
H 指数:13论文数:59被引数:1,934
Z
Zhilong Ma
H 指数:20论文数:57被引数:1,234